会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • HIGH LOAD ENZYME IMMOBILISATION BY CROSSLINKING
    • 通过交换来实现高负载消毒
    • WO2015150263A1
    • 2015-10-08
    • PCT/EP2015/056732
    • 2015-03-27
    • ROCHE DIAGNOSTICS GMBHF. HOFFMANN-LA ROCHE AGROCHE DIABETES CARE, INC.
    • HORN, CarinaGAWENDA, Susanne
    • C12N9/96C12N11/06C12N9/04G01N33/66
    • C12N11/06C12N9/0006C12N9/96C12N11/08C12Q1/001C12Q1/32C12Q1/54C12Y101/01047G01N2333/904
    • The present invention relates to a method for cross-linking polypeptide molecules, comprising the step of combining a cross-linking agent and polypeptide molecules in solution under conditions suitable for a cross-linking reaction to occur and to a preparation comprising cross-linked polypeptide molecules obtainable by said method. The present invention further relates to cross-linked polypeptide molecules, wherein said polypeptide molecules are cross-linked by essentially unbranched cross-linking groups comprising at least 40 contiguous atoms. Moreover, the present invention relates to a test chemistry matrix comprising a redox cofactor, an agent capable of eliciting a change in at least one measurable property of an indicator reagent in the presence of redox equivalents, and an indicator reagent, wherein said chemistry matrix further comprises a preparation of cross-linked polypeptide molecules obtainable by the method according to the present invention and/or cross-linked polypeptide molecules according tothe present invention, as well as to a diagnostic test element comprising said test chemistry matrix. The present invention further relates to a preparation of cross-linked polypeptide molecules obtainable by the method according the present invention and/or cross-linked polypeptide molecules according to the present invention for use in the diagnosis of disease and for use in diagnosis of diabetes, as well as to a method for producing a test chemistry matrix.
    • 本发明涉及交联多肽分子的方法,其包括在适于发生交联反应的条件下将溶液中的交联剂和多肽分子组合的步骤以及包含交联的多肽分子 可通过所述方法获得。 本发明还涉及交联的多肽分子,其中所述多肽分子通过基本上无支链的包含至少40个连续原子的交联基团交联。 此外,本发明涉及包含氧化还原辅因子,能够在氧化还原当量存在下引发指示剂的至少一种可测量性质的变化的试剂和指示剂的测试化学基质,其中所述化学基质进一步 包括通过根据本发明的方法可获得的交联多肽分子的制备和/或根据本发明的交联多肽分子,以及包含所述测试化学基质的诊断测试元件。 本发明还涉及通过本发明的方法获得的交联多肽分子的制备和/或根据本发明的交联多肽分子,其用于诊断疾病和用于诊断糖尿病, 以及生产测试化学基质的方法。
    • 5. 发明申请
    • REDOXINDICATORS
    • WO2016026959A1
    • 2016-02-25
    • PCT/EP2015/069249
    • 2015-08-21
    • ROCHE DIAGNOSTICS GMBHF. HOFFMANN-LA ROCHE AGROCHE DIAGNOSTICS OPERATIONS, INC.
    • GEBAUER, PeterHEINDL, DieterHORN, CarinaFOMIN, Maksim
    • C07D401/06C07D241/40
    • G01N33/52C07D241/40C07D241/42C07D401/06C07D403/06G01N33/5005
    • The present invention relates to a chemical compound or a salt or solvate thereof being a phenazine-, phenanthridine-, phenanthroline-, quinoline-, quinoxaline-, acridine- isoquinoline-, pyrazine- or pyridme-derivative comprising a conjugated π-system and a π-acceptor group, and to uses thereof. The present invention further relates to a chemistry matrix and to a test element comprising the chemical compound of the present invention. The present invention also relates to a method of determining the amount of an analyte in a test sample, comprising contacting said test sample with a chemical compound, with a chemistry matrix, or with a test element of the invention and estimating the amount of redox equivalents liberated or consumed by the chemical compound, by the chemical compound comprised in said chemistry matrix, or by the chemical compound comprised in said test element, in the presence of said test sample, thereby determining the amount of an analyte in said test sample. Moreover, the present invention relates to a system comprising a test element according to the present invention and a device comprising a sensor for measuring the amount of redox equivalents liberated or consumed.
    • 本发明涉及化合物或其盐或溶剂化物,其为包括共轭π系统的吩嗪,菲啶,菲咯啉,喹啉,喹喔啉,吖啶 - 异喹啉,吡嗪 - 或吡啶衍生物 π-受体基团及其用途。 本发明还涉及化学基质和包含本发明化合物的测试元件。 本发明还涉及确定测试样品中分析物的量的方法,包括使所述测试样品与化学基质或本发明的测试元件接触,并估算氧化还原当量的量 由所述化学基质中包含的化合物或由所述测试元件中包含的化合物在所述测试样品存在下释放或消耗,从而确定所述测试样品中分析物的量。 此外,本发明涉及包括根据本发明的测试元件的系统和包括用于测量释放或消耗的氧化还原当量的量的传感器的装置。
    • 7. 发明申请
    • COMPOSITION COMPRISING UP-CONVERTING PHOSPHORS FOR DETECTING AN ANALYTE
    • 包含用于检测分析仪的上转换磷的组合物
    • WO2015078899A1
    • 2015-06-04
    • PCT/EP2014/075639
    • 2014-11-26
    • ROCHE DIAGNOSTICS GMBHF. HOFFMANN-LA ROCHE AGROCHE DIAGNOSTICS OPERATIONS, INC.
    • HORN, CarinaVALTA, Timo-Jaakko
    • C12Q1/26C12Q1/54G01N33/52G01N33/66
    • G01N33/525C12Q1/26C12Q1/32C12Q1/54G01N21/77G01N33/521
    • The present invention relates to a detector matrix (130) for detecting at least one analyte in a sample, preferably a sample of a body fluid, comprising at least one enzyme active in the presence of said at least one analyte and at least one indicator reagent changing at least one optical property dependent on the activity of said enzyme, wherein said detector matrix (130) further comprises up-converting phosphor particles, preferably UV-emitting up-converting phosphor particles. The present invention further relates to a test element (120) and a test device (112) for detecting at least one analyte in a sample comprising the detector matrix (130) of the present invention, as well as to a method for the manufacture of a detector matrix(130), a method for the manufacture of a test element(120), and to a method for detecting an analyte in a sample, comprising contacting a detector matrix (130) according to the present invention with a sample suspected to comprise said analyte.
    • 本发明涉及一种检测器基体(130),用于检测样品中的至少一种分析物,优选体液样品,所述分析物在所述至少一种分析物和至少一种指示剂试剂存在下包含至少一种酶活性物质 改变取决于所述酶的活性的至少一种光学性质,其中所述检测器基质(130)还包括上转换荧光体颗粒,优选UV发射上转换磷光体颗粒。 本发明还涉及用于检测包括本发明的检测器基体(130)的样品中的至少一种分析物的测试元件(120)和测试装置(112),以及用于制造 检测器基体(130),用于制造测试元件(120)的方法以及用于检测样品中的分析物的方法,包括使根据本发明的检测器基体(130)与怀疑为 包括所述分析物。